サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：抗凝固剤市場- 薬剤クラス別、投与経路別、用途別、流通チャネル別、世界予測、2023年～2032年
市場調査レポート
商品コード
1305941

抗凝固剤市場- 薬剤クラス別、投与経路別、用途別、流通チャネル別、世界予測、2023年～2032年

Anticoagulants Market - By Drug Class (Factor Xa Inhibitors, Heparin), Route of Administration (Oral, Injectables), Application (Thromboembolism, Atrial Fibrillation, Coronary Artery Disease), Distribution Channel & Global Forecast, 2023 - 2032
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 181 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
抗凝固剤市場- 薬剤クラス別、投与経路別、用途別、流通チャネル別、世界予測、2023年～2032年
出版日: 2023年06月28日
発行: Global Market Insights Inc.
ページ情報: 英文 181 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

抗凝固剤の世界市場規模は2032年まで大きく拡大する疾患の早期診断に対する意識の高まりが市場成長の道を開く疾病診断に対する意識の高まりを受けて、世界各国の政府は、血栓や関連疾患を発症するリスクのある個人を特定するためのスクリーニング・プログラムや定期健康診断に投資しています。

また、製品メーカーは市場での地位を強化するため、高度な機能と最大限の有効性を備えた抗凝固剤の開発に注力しています。これらの要因が相俟って、抗凝固剤の売上は今後数年間にわたって促進されるでしょう。

抗凝固剤市場全体は、薬剤カテゴリー、投与経路、用途、流通チャネル、地域に基づいて分類されています。

薬剤カテゴリーに基づくと、ヘパリンセグメントの業界シェアは2023年から2032年にかけて有利なCAGRで成長します。深部静脈血栓症、急性冠症候群、心房細動、肺塞栓症、および血栓形成につながる他の疾患の有病率の増加が、ヘパリンの必要性を高めています。米国肺協会によると、肺塞栓症は米国だけで毎年約90万人が診断されています。

用途別では、心房細動／粗動セグメントによる抗凝固剤市場価値は、2032年までかなりの伸びを記録すると思われます。心房細動の増加が抗凝固剤の必要性を高めています。米国CDCによると、心房細動を主診断とする入院患者数は毎年45万4,000人を超えています。

流通チャネルの面では、市場セグメンテーションは2022年に抗凝固剤市場シェアの53.5％以上を占めました。割引価格で医薬品を入手しやすいことから、病院薬局を訪れる患者が増加しています。さらに、世界各国の政府による病院インフラへの投資の拡大が、病院薬局の数をさらに増加させています。これらの施設は患者中心のケアを提供し、最先端の医療機器を備えています。

地域別に見ると、欧州の抗凝固剤市場規模は2032年までに140億米ドルに達します。高齢者人口の増加と慢性疾患への罹患率が、同地域における抗凝固剤のニーズを高めています。心臓発作、脳卒中などの心臓疾患の負担が大きいことも、欧州での製品採用をさらに増加させています。この地域には、ベーリンガーインゲルハイム、バイエルAGなどの業界大手もあり、競合に打ち勝つために製品のイノベーションを重視しています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 抗凝固剤の業界考察

  • エコシステム分析
  • 業界への影響要因
    • 促進要因
      • 慢性疾患の増加
      • 新規経口抗凝固剤（NOAC）の採用拡大
      • 世界の高齢者人口の増加
    • 業界の潜在的リスク＆課題
      • 高い副作用リスク
      • 厳しい規制の枠組み
  • 成長可能性分析
    • 医薬品カテゴリー別
    • 投与経路別
    • 用途別
    • 流通チャネル別
  • COVID-19影響分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢、2022年

  • イントロダクション
  • 企業マトリックス分析（2022年）
  • 主要市場プレーヤーの競合分析
  • 競合のポジショニングマトリックス
  • 戦略ダッシュボード

第5章 抗凝固剤の市場規模・予測：薬効カテゴリー別

  • 主要動向：薬剤カテゴリー別
  • 第Xa因子阻害薬
  • ヘパリン
  • ワルファリン
  • 直接トロンビン阻害薬
  • その他

第6章 抗凝固剤の市場規模・予測：投与経路別

  • 主要動向：投与経路別
  • 経口
  • 注射剤

第7章 抗凝固剤の市場規模・予測：用途別

  • 主要動向：用途別
  • 静脈血栓塞栓症
  • 心房細動/粗動
  • 冠動脈疾患
  • その他

第8章 抗凝固剤の市場規模・予測：流通チャネル別

  • 主要動向：流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 抗凝固剤の市場規模・予測：地域別

  • 主要動向：地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東とアフリカ

第10章 企業プロファイル

  • Bristol-Myers Squibb Company
  • Bayer AG
  • Boehringer Ingelheim
  • Johnson and Johnson
  • Daiichi Sankyo Company
  • Amphastar Pharmaceuticals, Inc.
  • Leo pharma
  • Pfizer
  • ROVI
  • Sanofi
  • Shenzhen Hepalink
  • United Therapeutics
図表

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by drug category (2022)
  • TABLE 3 Market revenue, by route of administration (2022)
  • TABLE 4 Market revenue, by application (2022)
  • TABLE 5 Market share, by distribution channel (2022)
  • TABLE 6 Market share, by region (2022)
  • TABLE 7 Global anticoagulants market size, by drug category, 2018 - 2022 (USD Million)
  • TABLE 8 Global anticoagulants market size, by drug category, 2023 - 2032 (USD Million)
  • TABLE 9 Global anticoagulants market size, by route of administration, 2018 - 2022 (USD Million)
  • TABLE 10 Global anticoagulants market size, by route of administration, 2023 - 2032 (USD Million)
  • TABLE 11 Global anticoagulants market size, by application, 2018 - 2022 (USD Million)
  • TABLE 12 Global anticoagulants market size, by application, 2023 - 2032 (USD Million)
  • TABLE 13 Global nutraceuticals market size, by distribution channel, 2018 - 2022 (USD Million)
  • TABLE 14 Global nutraceuticals market size, by distribution channel, 2023 - 2032 (USD Million)
  • TABLE 15 Industry impact forces
  • TABLE 16 Factor Xa inhibitors market, by region, 2018 - 2022, (USD Million)
  • TABLE 17 Factor Xa inhibitors market, by region, 2023 - 2032, (USD Million)
  • TABLE 18 Heparin market, by region, 2018 - 2022, (USD Million)
  • TABLE 19 Heparin market, by region, 2023 - 2032, (USD Million)
  • TABLE 20 Warfarin market, by region, 2018 - 2022, (USD Million)
  • TABLE 21 Warfarin market, by region, 2023 - 2032, (USD Million)
  • TABLE 22 Direct thrombin inhibitors market, by region, 2018 - 2022, (USD Million)
  • TABLE 23 Direct thrombin inhibitors market, by region, 2023 - 2032, (USD Million)
  • TABLE 24 Others market, by region, 2018 - 2022, (USD Million)
  • TABLE 25 Others market, by region, 2023 - 2032, (USD Million)
  • TABLE 26 Oral market, by region, 2018 - 2022, (USD Million)
  • TABLE 27 Oral market, by region, 2023 - 2032, (USD Million)
  • TABLE 28 Injectable market, by region, 2018 - 2022, (USD Million)
  • TABLE 29 Injectable market, by region, 2023 - 2032, (USD Million)
  • TABLE 30 Venous thromboembolism market, by region, 2018 - 2022, (USD Million)
  • TABLE 31 Venous thromboembolism market, by region, 2023 - 2032, (USD Million)
  • TABLE 32 Atrial fibrillation/flutter market, by region, 2018 - 2022, (USD Million)
  • TABLE 33 Atrial fibrillation/flutter market, by region, 2023 - 2032, (USD Million)
  • TABLE 34 Coronary artery disease market, by region, 2018 - 2022, (USD Million)
  • TABLE 35 Coronary artery disease market, by region, 2023 - 2032, (USD Million)
  • TABLE 36 Others market, by region, 2018 - 2022, (USD Million)
  • TABLE 37 Others market, by region, 2023 - 2032, (USD Million)
  • TABLE 38 Hospital pharmacy market, by region, 2018 - 2022, (USD Million)
  • TABLE 39 Hospital pharmacy market, by region, 2023 - 2032, (USD Million)
  • TABLE 40 Retail pharmacy market, by region, 2018 - 2022, (USD Million)
  • TABLE 41 Retail pharmacy market, by region, 2023 - 2032, (USD Million)
  • TABLE 42 Online pharmacy market, by region, 2018 - 2022, (USD Million)
  • TABLE 43 Online pharmacy market, by region, 2023 - 2032, (USD Million)
  • TABLE 44 North America anticoagulants market, by country, 2018-2022, (USD Million)
  • TABLE 45 North America anticoagulants market, by country, 2023-2032, (USD Million)
  • TABLE 46 North America anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 47 North America anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 48 North America anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 49 North America anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 50 North America anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 51 North America anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 52 North America anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 53 North America anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 54 U.S. anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 55 U.S. anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 56 U.S. anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 57 U.S. anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 58 U.S. anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 59 U.S. anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 60 U.S. anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 61 U.S. anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 62 Canada anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 63 Canada anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 64 Canada anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 65 Canada anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 66 Canada anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 67 Canada anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 68 Canada ca anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 69 Canada anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 70 Europe anticoagulants market, by country, 2018-2022, (USD Million)
  • TABLE 71 Europe anticoagulants market, by country, 2023-2032, (USD Million)
  • TABLE 72 Europe anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 73 Europe anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 74 Europe anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 75 Europe anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 76 Europe anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 77 Europe anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 78 Europe anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 79 Europe anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 80 Germany anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 81 Germany anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 82 Germany anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 83 Germany anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 84 Germany anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 85 Germany anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 86 Germany anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 87 Germany anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 88 UK anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 89 UK anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 90 UK anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 91 UK anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 92 UK anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 93 UK anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 94 UK ca anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 95 UK anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 96 France anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 97 France anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 98 France anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 99 France anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 100 France anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 101 France anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 102 France anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 103 France anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 104 Italy anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 105 Italy anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 106 Italy anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 107 Italy anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 108 Italy anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 109 Italy anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 110 Italy anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 111 Italy anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 112 Spain anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 113 Spain anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 114 Spain anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 115 Spain anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 116 Spain anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 117 Spain anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 118 Spain anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 119 Spain anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 120 Rest of Europe anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 121 Rest of Europe anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 122 Rest of Europe anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 123 Rest of Europe anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 124 Rest of Europe anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 125 Rest of Europe anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 126 Rest of Europe anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 127 Asia Pacific anticoagulants market, by country, 2018-2022, (USD Million)
  • TABLE 128 Asia Pacific anticoagulants market, by country, 2023-2032, (USD Million)
  • TABLE 129 Asia Pacific anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 130 Asia Pacific anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 131 Asia Pacific anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 132 Asia Pacific anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 133 Asia Pacific anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 134 Asia Pacific anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 135 Asia Pacific anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 136 Asia Pacific anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 137 Japan anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 138 Japan anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 139 Japan anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 140 Japan anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 141 Japan anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 142 Japan anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 143 Japan anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 144 Japan anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 145 China anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 146 China anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 147 China anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 148 China anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 149 China anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 150 China anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 151 China anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 152 China anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 153 India anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 154 India anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 155 India anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 156 India anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 157 India anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 158 India anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 159 India anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 160 India anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 161 Australia anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 162 Australia anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 163 Australia anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 164 Australia anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 165 Australia anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 166 Australia anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 167 Australia anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 168 Australia anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 169 Rest of Asia Pacific anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 170 Rest of Asia Pacific anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 171 Rest of Asia Pacific anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 172 Rest of Asia Pacific anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 173 Rest of Asia Pacific anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 174 Rest of Asia Pacific anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 175 Rest of Asia Pacific anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 176 Rest of Asia Pacific anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 177 Latin America anticoagulants market, by country, 2018-2022, (USD Million)
  • TABLE 178 Latin America anticoagulants market, by country, 2023-2032, (USD Million)
  • TABLE 179 Latin America anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 180 Latin America anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 181 Latin America anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 182 Latin America anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 183 Latin America anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 184 Latin America anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 185 Latin America anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 186 Latin America anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 187 Brazil anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 188 Brazil anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 189 Brazil anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 190 Brazil anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 191 Brazil anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 192 Brazil anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 193 Brazil anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 194 Brazil anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 195 Mexico anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 196 Mexico anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 197 Mexico anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 198 Mexico anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 199 Mexico anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 200 Mexico anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 201 Mexico anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 202 Mexico anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 203 Argentina anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 204 Argentina anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 205 Argentina anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 206 Argentina anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 207 Argentina anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 208 Argentina anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 209 Argentina anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 210 Argentina anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 211 Rest of Latin America anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 212 Rest of Latin America anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 213 Rest of Latin America anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 214 Rest of Latin America anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 215 Rest of Latin America anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 216 Rest of Latin America anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 217 Rest of Latin America anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 218 Rest of Latin America anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 219 MEA anticoagulants market, by country, 2018-2022, (USD Million)
  • TABLE 220 MEA anticoagulants market, by country, 2023-2032, (USD Million)
  • TABLE 221 MEA anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 222 MEA anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 223 MEA anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 224 MEA anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 225 MEA anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 226 MEA anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 227 MEA anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 228 MEA anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 229 South Africa anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 230 South Africa anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 231 South Africa anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 232 South Africa anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 233 South Africa anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 234 South Africa anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 235 South Africa anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 236 South Africa anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 237 Saudi Arabia anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 238 Saudi Arabia anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 239 Saudi Arabia anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 240 Saudi Arabia anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 241 Saudi Arabia anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 242 Saudi Arabia anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 243 Saudi Arabia anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 244 Saudi Arabia anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 245 UAE anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 246 UAE anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 247 UAE anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 248 UAE anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 249 UAE anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 250 UAE anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 251 UAE anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 252 UAE anticoagulants market, by distribution channel, 2023-2032, (USD Million)
  • TABLE 253 Rest of MEA anticoagulants market, by product, 2018-2022, (USD Million)
  • TABLE 254 Rest of MEA anticoagulants market, by product, 2023-2032, (USD Million)
  • TABLE 255 Rest of MEA anticoagulants market, by route of administration, 2018-2022, (USD Million)
  • TABLE 256 Rest of MEA anticoagulants market, by route of administration, 2023-2032, (USD Million)
  • TABLE 257 Rest of MEA anticoagulants market, by application, 2018-2022, (USD Million)
  • TABLE 258 Rest of MEA anticoagulants market, by application, 2023-2032, (USD Million)
  • TABLE 259 Rest of MEA anticoagulants market, by distribution channel, 2018-2022, (USD Million)
  • TABLE 260 Rest of MEA anticoagulants market, by distribution channel, 2023-2032, (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Anticoagulants industry 36 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by drug category
  • FIG 8 Growth potential analysis, by route of administration
  • FIG 9 Growth potential analysis, by application
  • FIG 10 Growth potential analysis, by distribution channel
  • FIG 11 Porter's analysis
  • FIG 12 PESTEL analysis
  • FIG 13 Company matrix analysis, 2022
  • FIG 14 Competitive analysis of major market players, 2022
  • FIG 15 Competitive positioning matrix
  • FIG 16 Strategic dashboard, 2022
目次
Product Code: 4967

Global Anticoagulants Market size will expand significantly through 2032. Rising awareness about early disease diagnosis is paving the path for market growth. Owing to growing awareness about disease diagnosis, governments across the globe are investing in screening programs and routine health check-ups to identify individuals at risk of developing blood clots and related disorders. Besides, product manufacturers are focusing on developing anticoagulants with advanced capabilities and maximum efficacy to strengthen their market position. These factors, in tandem, will propel anticoagulant sales over the coming years.

The overall anticoagulants market is classified based on drug category, route of administration, application, distribution channel, and region.

Based on the drug category, industry share from the heparin segment will grow at a lucrative CAGR from 2023 to 2032. Increasing prevalence of deep vein thrombosis, acute coronary syndrome, atrial fibrillation, pulmonary embolism, and other disorders that lead to blood clot formation has increased the need for heparin. As per the American Lung Association, pulmonary embolism is diagnosed in around 900,000 people every year in the U.S. alone.

Based on application, the anticoagulants market value from the atrial fibrillation/Flutter segment will register considerable gains through 2032. Growing occurrence of atrial fibrillation has increased the need for anticoagulants. As per CDC, over 454,000 hospital admissions with atrial fibrillation as the primary diagnosis take place every year in the U.S. Moreover, surging product approvals by regulatory bodies for the treatment of this disease are further working in favor of segment growth.

In terms of distribution channel, the hospital pharmacy segment amassed over 53.5% of the anticoagulants market share in 2022. The ease of availability of medicines at discounted prices has increased patient visits to hospital pharmacies. Moreover, growing investment by governments across the globe in hospital infrastructure has further increased the number of hospital pharmacies. These facilities offer patient-centered care and are equipped with cutting-edge medical equipment.

From the regional perspective, Europe anticoagulants market size will reach USD 14 billion by 2032. Growing geriatric population and its susceptibility to chronic ailments have bolstered the need for anticoagulants in the region. The high burden of heart diseases such as heart attack, stroke, and others has further increased product adoption in Europe. The region is also home to industry giants, such as Boehringer Ingelheim, Bayer AG, and others, emphasizing product innovations to stand out in the competition, which will support regional expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Anticoagulants industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Drug category trends
    • 2.1.4 Route of administration trends
    • 2.1.5 Application trends
    • 2.1.6 Distribution channel trends

Chapter 3 Anticoagulants Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of chronic disease
      • 3.2.1.2 Growing adoption of novel oral anticoagulants (NOACs)
      • 3.2.1.3 Rising geriatric population across the globe
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High risk of side effects
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
    • 3.3.1 By drug category
    • 3.3.2 By route of administration
    • 3.3.3 By application
    • 3.3.4 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Anticoagulants Market Size and Forecast, By Drug Category (USD Million)

  • 5.1 Key trends, by drug category
  • 5.2 Factor Xa inhibitor
  • 5.3 Heparin
  • 5.4 Warfarin
  • 5.5 Direct thrombin inhibitor
  • 5.6 Others

Chapter 6 Anticoagulants Market Size and Forecast, By Route of Administration (USD Million)

  • 6.1 Key trends, by route of administration
  • 6.2 Oral
  • 6.3 Injectable

Chapter 7 Anticoagulants Market Size and Forecast, By Application (USD Million)

  • 7.1 Key trends, by application
  • 7.2 Venous thromboembolism
  • 7.3 Atrial fibrillation/flutter
  • 7.4 Coronary artery disease
  • 7.5 Others

Chapter 8 Anticoagulants Market Size and Forecast, By Distribution Channel (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacy
  • 8.3 Retail pharmacy
  • 8.4 Online pharmacy

Chapter 9 Anticoagulants Market Size and Forecast, By Region (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Bristol-Myers Squibb Company
  • 10.2 Bayer AG
  • 10.3 Boehringer Ingelheim
  • 10.4 Johnson and Johnson
  • 10.5 Daiichi Sankyo Company
  • 10.6 Amphastar Pharmaceuticals, Inc.
  • 10.7 Leo pharma
  • 10.8 Pfizer
  • 10.9 ROVI
  • 10.10 Sanofi
  • 10.11 Shenzhen Hepalink
  • 10.12 United Therapeutics